nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—Sorafenib—MAP2K5—restless legs syndrome	0.0643	1	CrCbGaD
Regorafenib—RET—autonomic nervous system—restless legs syndrome	0.0583	0.101	CbGeAlD
Regorafenib—KDR—hindlimb—restless legs syndrome	0.0401	0.0696	CbGeAlD
Regorafenib—KDR—appendage—restless legs syndrome	0.0344	0.0597	CbGeAlD
Regorafenib—BRAF—Trk receptor signaling mediated by the MAPK pathway—MAP2K5—restless legs syndrome	0.017	0.0474	CbGpPWpGaD
Regorafenib—DDR2—spinal cord—restless legs syndrome	0.0163	0.0282	CbGeAlD
Regorafenib—NTRK1—Circadian rythm related genes—BTBD9—restless legs syndrome	0.0151	0.042	CbGpPWpGaD
Regorafenib—DDR2—nervous system—restless legs syndrome	0.0137	0.0238	CbGeAlD
Regorafenib—FGFR2—brainstem—restless legs syndrome	0.0134	0.0232	CbGeAlD
Regorafenib—DDR2—central nervous system—restless legs syndrome	0.0132	0.0229	CbGeAlD
Regorafenib—MAPK11—nervous system—restless legs syndrome	0.013	0.0225	CbGeAlD
Regorafenib—MAPK11—central nervous system—restless legs syndrome	0.0125	0.0217	CbGeAlD
Regorafenib—RAF1—brainstem—restless legs syndrome	0.0123	0.0214	CbGeAlD
Regorafenib—RAF1—Trk receptor signaling mediated by the MAPK pathway—MAP2K5—restless legs syndrome	0.0118	0.0328	CbGpPWpGaD
Regorafenib—FGFR2—Cardiac Hypertrophic Response—MAP2K5—restless legs syndrome	0.0107	0.0299	CbGpPWpGaD
Regorafenib—DDR2—brain—restless legs syndrome	0.0105	0.0182	CbGeAlD
Regorafenib—MAPK11—brain—restless legs syndrome	0.00994	0.0172	CbGeAlD
Regorafenib—FGFR2—Ectoderm Differentiation—TOX3—restless legs syndrome	0.00979	0.0272	CbGpPWpGaD
Regorafenib—FGFR1—spinal cord—restless legs syndrome	0.00978	0.017	CbGeAlD
Regorafenib—KIT—brainstem—restless legs syndrome	0.00929	0.0161	CbGeAlD
Regorafenib—RET—spinal cord—restless legs syndrome	0.00875	0.0152	CbGeAlD
Regorafenib—BRAF—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.00841	0.0234	CbGpPWpGaD
Regorafenib—FGFR2—spinal cord—restless legs syndrome	0.00832	0.0144	CbGeAlD
Regorafenib—ABL1—brainstem—restless legs syndrome	0.00808	0.014	CbGeAlD
Regorafenib—RAF1—Cardiac Hypertrophic Response—MAP2K5—restless legs syndrome	0.00801	0.0223	CbGpPWpGaD
Regorafenib—TEK—spinal cord—restless legs syndrome	0.00797	0.0138	CbGeAlD
Regorafenib—FGFR2—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.0078	0.0217	CbGpPWpGaD
Regorafenib—FLT1—spinal cord—restless legs syndrome	0.00771	0.0134	CbGeAlD
Regorafenib—RAF1—spinal cord—restless legs syndrome	0.00766	0.0133	CbGeAlD
Regorafenib—FGFR2—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.00765	0.0213	CbGpPWpGaD
Regorafenib—FLT1—Focal Adhesion—MAP2K5—restless legs syndrome	0.00758	0.0211	CbGpPWpGaD
Regorafenib—BRAF—brain—restless legs syndrome	0.00741	0.0129	CbGeAlD
Regorafenib—RET—nervous system—restless legs syndrome	0.00737	0.0128	CbGeAlD
Regorafenib—FGFR1—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.00727	0.0202	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.00725	0.0202	CbGpPWpGaD
Regorafenib—PDGFRA—spinal cord—restless legs syndrome	0.00722	0.0125	CbGeAlD
Regorafenib—BRAF—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.00718	0.02	CbGpPWpGaD
Regorafenib—RET—central nervous system—restless legs syndrome	0.0071	0.0123	CbGeAlD
Regorafenib—EPHX2—brain—restless legs syndrome	0.00708	0.0123	CbGeAlD
Regorafenib—FGFR2—nervous system—restless legs syndrome	0.00701	0.0122	CbGeAlD
Regorafenib—BRAF—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.0069	0.0192	CbGpPWpGaD
Regorafenib—EPHA2—nervous system—restless legs syndrome	0.00689	0.0119	CbGeAlD
Regorafenib—FGFR2—central nervous system—restless legs syndrome	0.00675	0.0117	CbGeAlD
Regorafenib—TEK—nervous system—restless legs syndrome	0.00672	0.0117	CbGeAlD
Regorafenib—NTRK1—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.00666	0.0185	CbGpPWpGaD
Regorafenib—EPHA2—central nervous system—restless legs syndrome	0.00663	0.0115	CbGeAlD
Regorafenib—PDGFRB—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.00653	0.0182	CbGpPWpGaD
Regorafenib—KDR—spinal cord—restless legs syndrome	0.00652	0.0113	CbGeAlD
Regorafenib—FLT1—nervous system—restless legs syndrome	0.00649	0.0113	CbGeAlD
Regorafenib—TEK—central nervous system—restless legs syndrome	0.00647	0.0112	CbGeAlD
Regorafenib—RAF1—nervous system—restless legs syndrome	0.00646	0.0112	CbGeAlD
Regorafenib—FLT4—brain—restless legs syndrome	0.00638	0.0111	CbGeAlD
Regorafenib—FGFR1—brain—restless legs syndrome	0.0063	0.0109	CbGeAlD
Regorafenib—KIT—Differentiation Pathway—TF—restless legs syndrome	0.00628	0.0175	CbGpPWpGaD
Regorafenib—FLT1—central nervous system—restless legs syndrome	0.00625	0.0108	CbGeAlD
Regorafenib—RAF1—central nervous system—restless legs syndrome	0.00622	0.0108	CbGeAlD
Regorafenib—PDGFRA—nervous system—restless legs syndrome	0.00609	0.0106	CbGeAlD
Regorafenib—RET—SIDS Susceptibility Pathways—TF—restless legs syndrome	0.0059	0.0164	CbGpPWpGaD
Regorafenib—NTRK1—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.00589	0.0164	CbGpPWpGaD
Regorafenib—PDGFRA—central nervous system—restless legs syndrome	0.00586	0.0102	CbGeAlD
Regorafenib—RAF1—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.00582	0.0162	CbGpPWpGaD
Regorafenib—KIT—spinal cord—restless legs syndrome	0.00577	0.01	CbGeAlD
Regorafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.00571	0.0159	CbGpPWpGaD
Regorafenib—PDGFRB—spinal cord—restless legs syndrome	0.00564	0.00978	CbGeAlD
Regorafenib—RET—brain—restless legs syndrome	0.00564	0.00978	CbGeAlD
Regorafenib—KDR—nervous system—restless legs syndrome	0.00549	0.00952	CbGeAlD
Regorafenib—FGFR2—brain—restless legs syndrome	0.00536	0.00929	CbGeAlD
Regorafenib—KDR—central nervous system—restless legs syndrome	0.00529	0.00917	CbGeAlD
Regorafenib—EPHA2—brain—restless legs syndrome	0.00526	0.00913	CbGeAlD
Regorafenib—TEK—brain—restless legs syndrome	0.00513	0.00891	CbGeAlD
Regorafenib—KDR—Focal Adhesion—MAP2K5—restless legs syndrome	0.00504	0.014	CbGpPWpGaD
Regorafenib—ABL1—spinal cord—restless legs syndrome	0.00503	0.00872	CbGeAlD
Regorafenib—NTRK1—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.005	0.0139	CbGpPWpGaD
Regorafenib—MAPK11—Insulin Signaling—MAP2K5—restless legs syndrome	0.00498	0.0139	CbGpPWpGaD
Regorafenib—RAF1—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.00497	0.0138	CbGpPWpGaD
Regorafenib—FLT1—brain—restless legs syndrome	0.00496	0.00861	CbGeAlD
Regorafenib—RAF1—brain—restless legs syndrome	0.00494	0.00856	CbGeAlD
Regorafenib—BRAF—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00488	0.0136	CbGpPWpGaD
Regorafenib—RAF1—Ion channel transport—FXYD1—restless legs syndrome	0.00487	0.0136	CbGpPWpGaD
Regorafenib—KIT—nervous system—restless legs syndrome	0.00487	0.00844	CbGeAlD
Regorafenib—RAF1—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.00478	0.0133	CbGpPWpGaD
Regorafenib—PDGFRB—nervous system—restless legs syndrome	0.00475	0.00824	CbGeAlD
Regorafenib—BRAF—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.00474	0.0132	CbGpPWpGaD
Regorafenib—KIT—central nervous system—restless legs syndrome	0.00468	0.00813	CbGeAlD
Regorafenib—PDGFRA—brain—restless legs syndrome	0.00465	0.00807	CbGeAlD
Regorafenib—PDGFRB—central nervous system—restless legs syndrome	0.00458	0.00794	CbGeAlD
Regorafenib—ABCG2—Iron uptake and transport—TF—restless legs syndrome	0.00454	0.0126	CbGpPWpGaD
Regorafenib—BRAF—Focal Adhesion—MAP2K5—restless legs syndrome	0.0043	0.012	CbGpPWpGaD
Regorafenib—ABL1—nervous system—restless legs syndrome	0.00424	0.00735	CbGeAlD
Regorafenib—KDR—brain—restless legs syndrome	0.0042	0.00728	CbGeAlD
Regorafenib—FGFR1—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.0041	0.0114	CbGpPWpGaD
Regorafenib—ABL1—central nervous system—restless legs syndrome	0.00408	0.00707	CbGeAlD
Regorafenib—MAPK11—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00407	0.0113	CbGpPWpGaD
Regorafenib—BRAF—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00403	0.0112	CbGpPWpGaD
Regorafenib—NTRK1—Signaling by NGF—MAP2K5—restless legs syndrome	0.00385	0.0107	CbGpPWpGaD
Regorafenib—FGFR2—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00373	0.0104	CbGpPWpGaD
Regorafenib—KIT—brain—restless legs syndrome	0.00372	0.00645	CbGeAlD
Regorafenib—RAF1—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.00371	0.0103	CbGpPWpGaD
Regorafenib—PDGFRA—Focal Adhesion—MAP2K5—restless legs syndrome	0.0037	0.0103	CbGpPWpGaD
Regorafenib—ABL1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00369	0.0103	CbGpPWpGaD
Regorafenib—PDGFRB—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.00368	0.0102	CbGpPWpGaD
Regorafenib—KIT—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00367	0.0102	CbGpPWpGaD
Regorafenib—PDGFRB—brain—restless legs syndrome	0.00363	0.0063	CbGeAlD
Regorafenib—FGFR1—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00348	0.00968	CbGpPWpGaD
Regorafenib—PDGFRA—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00347	0.00966	CbGpPWpGaD
Regorafenib—RAF1—Insulin Signaling—MAP2K5—restless legs syndrome	0.00341	0.00949	CbGpPWpGaD
Regorafenib—RAF1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00338	0.0094	CbGpPWpGaD
Regorafenib—PDGFRB—Focal Adhesion—MAP2K5—restless legs syndrome	0.00333	0.00928	CbGpPWpGaD
Regorafenib—RAF1—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.00328	0.00913	CbGpPWpGaD
Regorafenib—ABL1—brain—restless legs syndrome	0.00324	0.00562	CbGeAlD
Regorafenib—ABCG2—HIF-1-alpha transcription factor network—TF—restless legs syndrome	0.00323	0.00898	CbGpPWpGaD
Regorafenib—ABCG2—spinal cord—restless legs syndrome	0.00317	0.0055	CbGeAlD
Regorafenib—MAPK11—Signaling by NGF—MAP2K5—restless legs syndrome	0.00313	0.0087	CbGpPWpGaD
Regorafenib—PDGFRB—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00313	0.0087	CbGpPWpGaD
Regorafenib—BRAF—Signaling by NGF—MAP2K5—restless legs syndrome	0.0031	0.00862	CbGpPWpGaD
Regorafenib—RAF1—Focal Adhesion—MAP2K5—restless legs syndrome	0.00297	0.00827	CbGpPWpGaD
Regorafenib—FGFR2—Signaling by NGF—MAP2K5—restless legs syndrome	0.00287	0.00799	CbGpPWpGaD
Regorafenib—KIT—Signaling by NGF—MAP2K5—restless legs syndrome	0.00282	0.00785	CbGpPWpGaD
Regorafenib—RAF1—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00279	0.00776	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by NGF—MAP2K5—restless legs syndrome	0.00268	0.00745	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by NGF—MAP2K5—restless legs syndrome	0.00267	0.00743	CbGpPWpGaD
Regorafenib—CYP2B6—nervous system—restless legs syndrome	0.00246	0.00427	CbGeAlD
Regorafenib—PDGFRB—Signaling by NGF—MAP2K5—restless legs syndrome	0.0024	0.00669	CbGpPWpGaD
Regorafenib—CYP2B6—central nervous system—restless legs syndrome	0.00237	0.00412	CbGeAlD
Regorafenib—RAF1—Signaling by NGF—MAP2K5—restless legs syndrome	0.00214	0.00596	CbGpPWpGaD
Regorafenib—CYP2C8—brain—restless legs syndrome	0.0021	0.00364	CbGeAlD
Regorafenib—MAPK11—Glucocorticoid receptor regulatory network—POMC—restless legs syndrome	0.00209	0.00582	CbGpPWpGaD
Regorafenib—TEK—Hemostasis—TF—restless legs syndrome	0.00205	0.00571	CbGpPWpGaD
Regorafenib—ABCG2—brain—restless legs syndrome	0.00204	0.00354	CbGeAlD
Regorafenib—BRAF—Corticotropin-releasing hormone—POMC—restless legs syndrome	0.00189	0.00525	CbGpPWpGaD
Regorafenib—CYP2B6—brain—restless legs syndrome	0.00188	0.00327	CbGeAlD
Regorafenib—CYP3A4—nervous system—restless legs syndrome	0.00186	0.00323	CbGeAlD
Regorafenib—CYP3A4—central nervous system—restless legs syndrome	0.00179	0.00311	CbGeAlD
Regorafenib—ABCB1—HIF-1-alpha transcription factor network—TF—restless legs syndrome	0.00174	0.00485	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	0.0017	0.00472	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—MAP2K5—restless legs syndrome	0.00157	0.00438	CbGpPWpGaD
Regorafenib—ABCB1—spinal cord—restless legs syndrome	0.00156	0.00271	CbGeAlD
Regorafenib—ABCG2—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	0.00148	0.00412	CbGpPWpGaD
Regorafenib—RAF1—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.00141	0.00391	CbGpPWpGaD
Regorafenib—ABCB1—nervous system—restless legs syndrome	0.00132	0.00228	CbGeAlD
Regorafenib—RAF1—Corticotropin-releasing hormone—POMC—restless legs syndrome	0.00131	0.00364	CbGpPWpGaD
Regorafenib—ABCB1—central nervous system—restless legs syndrome	0.00127	0.0022	CbGeAlD
Regorafenib—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.00118	0.00327	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—MAP2K5—restless legs syndrome	0.00117	0.00327	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	0.00106	0.00294	CbGpPWpGaD
Regorafenib—ABCB1—brain—restless legs syndrome	0.00101	0.00175	CbGeAlD
Regorafenib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.000995	0.00277	CbGpPWpGaD
Regorafenib—CYP2B6—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	0.000953	0.00265	CbGpPWpGaD
Regorafenib—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.000888	0.00247	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—MAP2K5—restless legs syndrome	0.000826	0.0023	CbGpPWpGaD
Regorafenib—UGT1A1—Biological oxidations—POMC—restless legs syndrome	0.000814	0.00227	CbGpPWpGaD
Regorafenib—UGT1A9—Biological oxidations—POMC—restless legs syndrome	0.000814	0.00227	CbGpPWpGaD
Regorafenib—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.00081	0.00225	CbGpPWpGaD
Regorafenib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	0.000807	0.00225	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—FXYD1—restless legs syndrome	0.0008	0.00223	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—TF—restless legs syndrome	0.000793	0.00221	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—MAP2K5—restless legs syndrome	0.000781	0.00217	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—TF—restless legs syndrome	0.000725	0.00202	CbGpPWpGaD
Regorafenib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	0.00072	0.002	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—MAP2K5—restless legs syndrome	0.000672	0.00187	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MAP2K5—restless legs syndrome	0.000665	0.00185	CbGpPWpGaD
Regorafenib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	0.000657	0.00183	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—TF—restless legs syndrome	0.000628	0.00175	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MAP2K5—restless legs syndrome	0.000617	0.00172	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MAP2K5—restless legs syndrome	0.000606	0.00169	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MAP2K5—restless legs syndrome	0.000575	0.0016	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MAP2K5—restless legs syndrome	0.000573	0.0016	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—TF—restless legs syndrome	0.000547	0.00152	CbGpPWpGaD
Regorafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.000534	0.00149	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MAP2K5—restless legs syndrome	0.000516	0.00144	CbGpPWpGaD
Regorafenib—CYP2B6—Biological oxidations—POMC—restless legs syndrome	0.000506	0.00141	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—POMC—restless legs syndrome	0.00047	0.00131	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MAP2K5—restless legs syndrome	0.00046	0.00128	CbGpPWpGaD
Regorafenib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	0.000433	0.00121	CbGpPWpGaD
Regorafenib—CYP2C8—Biological oxidations—POMC—restless legs syndrome	0.000429	0.00119	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—POMC—restless legs syndrome	0.000387	0.00108	CbGpPWpGaD
Regorafenib—CYP2C19—Biological oxidations—POMC—restless legs syndrome	0.000382	0.00106	CbGpPWpGaD
Regorafenib—CYP2C9—Biological oxidations—POMC—restless legs syndrome	0.000349	0.000971	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	0.000312	0.00087	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—TF—restless legs syndrome	0.000296	0.000824	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—POMC—restless legs syndrome	0.000289	0.000804	CbGpPWpGaD
Regorafenib—CYP3A4—Biological oxidations—POMC—restless legs syndrome	0.00023	0.00064	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—POMC—restless legs syndrome	0.000203	0.000566	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—POMC—restless legs syndrome	0.000192	0.000535	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—POMC—restless legs syndrome	0.000192	0.000533	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—POMC—restless legs syndrome	0.000165	0.00046	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	0.000165	0.000458	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—POMC—restless legs syndrome	0.000164	0.000455	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—POMC—restless legs syndrome	0.000152	0.000422	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—POMC—restless legs syndrome	0.000149	0.000415	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	0.000147	0.000409	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—POMC—restless legs syndrome	0.000141	0.000393	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—POMC—restless legs syndrome	0.000141	0.000392	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—POMC—restless legs syndrome	0.000139	0.000387	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—POMC—restless legs syndrome	0.000139	0.000387	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	0.000134	0.000373	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—POMC—restless legs syndrome	0.000127	0.000354	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—POMC—restless legs syndrome	0.000118	0.000329	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—POMC—restless legs syndrome	0.000113	0.000315	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—POMC—restless legs syndrome	8.66e-05	0.000241	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—POMC—restless legs syndrome	7.33e-05	0.000204	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—POMC—restless legs syndrome	6.54e-05	0.000182	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—POMC—restless legs syndrome	6.38e-05	0.000178	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—POMC—restless legs syndrome	5.96e-05	0.000166	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—POMC—restless legs syndrome	3.93e-05	0.000109	CbGpPWpGaD
